You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Kimberly-Clark completed its acquisition of Kenview and targets $1.9 billion in cost synergies, with integration execution and brand investment central to the combination.
Kimberly-Clark completed the Kenvue acquisition on November 2, 2026 for approximately $6.7 billion in cash consideration and 281.1 million shares. Its integration program targets operating profit synergies by 2030 and expects approximately $3.1 billion in cumulative pre-tax charges.
Kimberly-Clark completed its Kenvue acquisition and reported third-quarter net sales of $4.1 billion, down 0.4 percent, while reaffirming its 2026 standalone outlook.
Kimberly-Clark Corporation completed exchange offers on November 4, 2026, issuing $6,376,039,000 of unsecured senior notes to holders of Kenvue notes.
Kimberly-Clark Corporation completed its acquisition of Kenvue on November 2, 2026. The integration program is expected to generate $3.1 billion in cumulative pre-tax charges through December 31, 2029.
Useful current figures from the complete screener profile.
TL;DR. Kimberly-Clark posted Q2 adjusted EPS of $1.80 (+10.4% YoY) and 10th consecutive quarter of volume-plus-mix growth, but lowered 2026 outlook due to ~100 bps China diaper disruption and ~$150M back-half input cost headwind, with adjusted EPS attributable to KMB now expected to decline low single digits.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Earnings per Share Attributable to Kimberly-Clark non-GAAP | $1.7 | Three Months Ended September 30, 2026 | — |
|
|
|||
| Adjusted Earnings per Share from Continuing Operations non-GAAP | $1.7 | Three Months Ended September 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Diluted Earnings per Share from Continuing Operations $1.19
+$0.13 2024 Transformation Initiative
+$0.27 Kenvue Acquisition
+$0 U.S. Tax Reform Related Matters (OBBBA)
+$0.12 Equity Company Adjustments
+$0 IFP Repatriated Earnings
-$0.01 Unrealized (Gains) Losses on Commodity Hedges
= Adjusted Earnings per Share from Continuing Operations $1.7
|
|||
| Adjusted Effective Tax Rate non-GAAP | 19.5% | Three Months Ended September 30, 2026 | — |
|
|
|||
| Adjusted Gross Profit non-GAAP | $1.47B | Three Months Ended September 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Gross Profit $1.44B
+$29M 2024 Transformation Initiative
-$2M Unrealized (Gains) Losses on Commodity Hedges
= Adjusted Gross Profit $1.47B
|
|||
| Adjusted Operating Profit non-GAAP | $677M | Three Months Ended September 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Operating Profit $516M
+$55M 2024 Transformation Initiative
+$106M Kenvue Acquisition
+$2M Brazil Business Tax Credits
-$2M Unrealized (Gains) Losses on Commodity Hedges
= Adjusted Operating Profit $677M
|
|||
| Organic Sales Growth non-GAAP | -1.3% | Three Months Ended September 30, 2026 | — |
|
|
|||
| 2024 Transformation Initiative charges (pre-tax) | 54M | the three months ended June 30, 2026 filing | — |
| Adjusted Earnings per Share non-GAAP | $1.8 | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Diluted Earnings per Share $1.22
+$0.12 2024 Transformation Initiative
+$0.3 Kenvue Acquisition
-$0.1 Brazil Business Tax Credits
+$0.26 IFP Repatriated Earnings
= Adjusted Earnings per Share $1.8
|
|||
| Adjusted EPS attributable to Kimberly-Clark non-GAAP | $4.09 | first half of 2026 (year-to-date) | — |
| Adjusted EPS from continuing operations non-GAAP | $3.4 | first half of 2026 (year-to-date) | — |
| Adjusted gross margin non-GAAP | 38.3% | first half of 2026 (year-to-date) | — |
| Adjusted Income from Discontinued Operations non-GAAP | $107M | Three Months Ended June 30, 2026 | — |
| Adult Care sales | 493M | the three months ended June 30, 2026 filing | — |
| Aggregate notional value of forward-starting interest rate swaps entered into | 4.3B | In the second quarter of 2026 filing | — |
| All other sales | 30M | the three months ended June 30, 2026 filing | — |
| Baby and Child Care sales | 1.75B | the three months ended June 30, 2026 filing | — |
| Corporate & Other capital spending | 29M | the three months ended June 30, 2026 filing | — |
| Family Care sales | 1.02B | the three months ended June 30, 2026 filing | — |
| Feminine Care sales | 423M | the three months ended June 30, 2026 filing | — |
| IPC capital spending | 50M | the three months ended June 30, 2026 filing | — |
| IPC depreciation and amortization | 50M | the three months ended June 30, 2026 filing | — |
| NA capital spending | 206M | the three months ended June 30, 2026 filing | — |
| NA depreciation and amortization | 117M | the three months ended June 30, 2026 filing | — |
| Organic non-GAAP | -0.1% | the three months ended June 30, 2026 filing | — |
| Organic sales growth (IPC) non-GAAP | 1% | the quarter | — |
GAAP → non-GAAP reconciliationGAAP Net Sales Growth - IPC 4%
-3.1% Currency Translation
+0.1% Divestitures and Business Exits
= Organic Sales Growth - IPC 1%
|
|||
| Professional sales | 476M | the three months ended June 30, 2026 filing | — |
| Segment Operating Profit non-GAAP | 911M | Three Months Ended June 30 | — |
GAAP → non-GAAP reconciliationGAAP Total Operating Profit 633M
+278M Corporate & Other
= Segment Operating Profit 911M
|
|||
| Total Segment Capital Spending | $256M | the three months ended June 30, 2026 filing | — |
| Total Segment Depreciation and Amortization | 167M | the three months ended June 30, 2026 filing | — |
| Year-to-date organic sales (IPC) non-GAAP | 2.5% | Year-to-date | — |
| Year-to-date organic sales (NA) non-GAAP | 0.5% | Year-to-date | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KMB
this stock
Kimberly Clark Corp
|
$36.40B | +8.5% | -2.1% | 11.0 | 15.9% |
|
PG
PROCTER & GAMBLE Co
|
$393.56B | +18.5% | +3.3% | 25.6 | 1.0% |
|
UL
Unilever PLC
|
$142.57B | +1.2% | — | — | 0.3% |
|
CL
Colgate Palmolive Co
|
$79.23B | +26.1% | +1.7% | 38.9 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$47.99B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Kimberly-Clark completed the Kenvue acquisition on November 2, 2026 for approximately $6.7 billion in cash consideration and 281.1 million shares. Its integration program targets operating profit synergies by 2030 and expects approximately $3.1 billion in cumulative pre-tax charges.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KMB | +0.9% | +3.7% | +10.8% | +1.4% | +8.5% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -1.7% | +4.8% | +10.3% | +1.6% | -2.2% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
